1.62078380 bw - Sentry expands specialty pharmacy capabilities via new partnership with Avella

Sentry expands specialty pharmacy capabilities via new partnership with Avella

Sentry has just entered a new partnership with Avella Specialty Pharmacy, one of the nation’s leading specialty pharmacies, known for high-touch customer service. This collaboration will allow both organizations to leverage their strengths in order to better serve covered entities participating in the 340B drug discount program.

“Our goal is to provide a total pharmacy management solution for our customers,” said Sentry’s CEO and founder, Travis Leonardi, RPh. “As a recognized leader in pharmacy utilization management, optimization and analytics, our customers count on us to help solve their pharmacy business challenges. Our relationship with Avella helps strengthen our customer’s clinical capabilities, as well.”

As Sentry has seen growth in providers’ use of specialty medications to treat complicated health conditions, they’ve also seen these providers struggle with how to gain access to specialty medications and how to manage the high cost of these therapies. By joining forces with Avella, Sentry’s 340B customers will now be able to incorporate specialty medications as part of their 340B program and will have improved access to hard-to-obtain drugs. In addition, they can leverage Avella’s expertise to help ensure medication adherence, improve outcomes and reduce readmissions of patients with complex health concerns, such as cancer, rheumatoid arthritis, Crohn’s disease, multiple sclerosis, hepatitis and HIV/AIDS.

“We are honored that Sentry has selected Avella as a strategic partner in this initiative,” said Nathan Downhour, Executive Vice President of Strategic Programs for Avella. “We recognized that they are a leader in the 340B space and as such, their efforts have helped thousands of healthcare organizations provide affordable drugs to providers participating in the 340B program.”

Sentry’s proprietary technology drives an integrated platform for advanced analytics, procurement, drug utilization, inventory, audit and compliance solutions. The company also has more than a decade of 340B experience and, like Avella, employs a team of pharmacists, support staff and clinical professionals. Avella will bring nearly two decades of expertise in the specialty pharmacy space to this partnership, including its roles in providing breakthrough medications and support to patients, as well as deep relationships with providers, payers and drug manufacturers.

“There is incredible synergy between our two companies as we both understand the importance of merging advanced technology with clinical expertise. Yet, we cover different ends of the 340B spectrum,” said Dr. William T. Sander, PharmD, Executive Vice President of Sales for Sentry. “Avella’s long-standing history of clinical excellence, and ability to effectively partner with practices, makes them an ideal partner for Sentry.”

About Avella Specialty Pharmacy

Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella’s clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. Avella reached 1,772th on Inc. magazine’s 2014 list of the 5,000 fastest-growing private companies in the country. In addition, the Arizona Corporate Excellence Awards has named Avella Specialty Pharmacy as the fastest-growing private company based in the state. For more information, please visit www.avella.com.